<DOC>
	<DOCNO>NCT00550433</DOCNO>
	<brief_summary>The purpose clinical trial study blood level drug ( conjugate estrogen ) body one dosage form compare another . The four formulation study drug eligible participant receive contain amount medication . In addition , information also obtain regard safety tolerability formulation give healthy postmenopausal woman .</brief_summary>
	<brief_title>Study Evaluating Bazedoxifene/CE Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Postmenopausal woman age 35 70 year . Spontaneous surgical amenorrhea least 6 month . Body mass index ( BMI ) range 18.0 35.0 kg/m2 body weight great equal 50 kg . Hypertension elevate supine blood pressure ( &gt; 139 mm Hg systolic &gt; 89 mm Hg diastolic ) . History clinically important drug allergy . Use prescription investigational drug within 30 day test article administration .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>